234 related articles for article (PubMed ID: 35524933)
1. Clonal Hematopoiesis and Myeloid Neoplasms in the Context of Telomere Biology Disorders.
Ferrer A; Mangaonkar AA; Patnaik MM
Curr Hematol Malig Rep; 2022 Jun; 17(3):61-68. PubMed ID: 35524933
[TBL] [Abstract][Full Text] [Related]
2. Adaptive and Maladaptive Clonal Hematopoiesis in Telomere Biology Disorders.
Lasho T; Patnaik MM
Curr Hematol Malig Rep; 2024 Feb; 19(1):35-44. PubMed ID: 38095828
[TBL] [Abstract][Full Text] [Related]
3. Therapy-selected clonal hematopoiesis and its role in myeloid neoplasms.
Jahn J; Diamond B; Hsu J; Montoya S; Totiger TM; Landgren O; Maura F; Taylor J
Leuk Res; 2023 Mar; 126():107020. PubMed ID: 36696829
[TBL] [Abstract][Full Text] [Related]
4. The role of clonal hematopoiesis as driver of therapy-related myeloid neoplasms after autologous stem cell transplantation.
Gramegna D; Bertoli D; Cattaneo C; Almici C; Re A; Belotti A; Borlenghi E; Lanzi G; Archetti S; Verardi R; Brugnoni D; Sciumè M; Daffini R; Roccaro AM; Tucci A; Rossi G
Ann Hematol; 2022 Jun; 101(6):1227-1237. PubMed ID: 35380239
[TBL] [Abstract][Full Text] [Related]
5. Telomere biology disorder prevalence and phenotypes in adults with familial hematologic and/or pulmonary presentations.
Feurstein S; Adegunsoye A; Mojsilovic D; Vij R; West DePersia AH; Rajagopal PS; Osman A; Collins RH; Kim RH; Gore SD; Greenberg P; Godley LA; Li Z; Del Gaudio D; Subramanian HP; Das S; Walsh T; Gulsuner S; Segal JP; Husain AN; Gurbuxani S; King MC; Strek ME; Churpek JE
Blood Adv; 2020 Oct; 4(19):4873-4886. PubMed ID: 33035329
[TBL] [Abstract][Full Text] [Related]
6. How predictive is the finding of clonal hematopoiesis for the development of myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML)?
Steensma DP
Best Pract Res Clin Haematol; 2021 Dec; 34(4):101327. PubMed ID: 34865699
[TBL] [Abstract][Full Text] [Related]
7. Clonal hematopoiesis and preleukemia-Genetics, biology, and clinical implications.
Hartmann L; Metzeler KH
Genes Chromosomes Cancer; 2019 Dec; 58(12):828-838. PubMed ID: 30939217
[TBL] [Abstract][Full Text] [Related]
8. Lymphoid clonal hematopoiesis: implications for malignancy, immunity, and treatment.
von Beck K; von Beck T; Ferrell PB; Bick AG; Kishtagari A
Blood Cancer J; 2023 Jan; 13(1):5. PubMed ID: 36599826
[TBL] [Abstract][Full Text] [Related]
9. The lifelong natural history of clonal hematopoiesis and its links to myeloid neoplasia.
Fabre MA; Vassiliou GS
Blood; 2024 Feb; 143(7):573-581. PubMed ID: 37992214
[TBL] [Abstract][Full Text] [Related]
10. Clinical manifestations of clonal hematopoiesis: What has SF3B1-mutant MDS taught us?
Todisco G; Moura PL; Hellström-Lindberg E
Semin Hematol; 2022 Jul; 59(3):150-155. PubMed ID: 36115692
[TBL] [Abstract][Full Text] [Related]
11. Familial Clonal Hematopoiesis in a Long Telomere Syndrome.
DeBoy EA; Tassia MG; Schratz KE; Yan SM; Cosner ZL; McNally EJ; Gable DL; Xiang Z; Lombard DB; Antonarakis ES; Gocke CD; McCoy RC; Armanios M
N Engl J Med; 2023 Jun; 388(26):2422-2433. PubMed ID: 37140166
[TBL] [Abstract][Full Text] [Related]
12. Clonal hematopoiesis in cancer.
Park SJ; Bejar R
Exp Hematol; 2020 Mar; 83():105-112. PubMed ID: 32044376
[TBL] [Abstract][Full Text] [Related]
13. Implementation of a prospective screening strategy to identify adults with a telomere biology disorder among those undergoing lung transplant evaluation for interstitial lung disease.
Banaszak LG; Smith-Simmer K; Shoger K; Lovrien L; Malik A; Sandbo N; Sultan S; Guzy R; Lowery EM; Churpek JE
Respir Med; 2023 Dec; 220():107464. PubMed ID: 37951311
[TBL] [Abstract][Full Text] [Related]
14. Myeloid neoplasms and clonal hematopoiesis from the RUNX1 perspective.
Hayashi Y; Harada Y; Harada H
Leukemia; 2022 May; 36(5):1203-1214. PubMed ID: 35354921
[TBL] [Abstract][Full Text] [Related]
15. Prognostic relevance of clonal hematopoiesis in myeloid neoplastic transformation in patients with follicular lymphoma treated with radioimmunotherapy.
Xie Z; Lasho T; Khurana A; Ferrer A; Finke C; Mangaonkar AA; Ansell S; Fernandez J; Shah MV; Al-Kali A; Gangat N; Abeykoon J; Witzig TE; Patnaik MM
Haematologica; 2024 Feb; 109(2):509-520. PubMed ID: 37646653
[TBL] [Abstract][Full Text] [Related]
16. [Clonal hematopoiesis and solid neoplasms].
Arends CM; Damm F
Inn Med (Heidelb); 2022 Nov; 63(11):1133-1140. PubMed ID: 36149440
[TBL] [Abstract][Full Text] [Related]
17. The crossroads of cancer therapies and clonal hematopoiesis.
Singh A; Balasubramanian S
Semin Hematol; 2024 Feb; 61(1):16-21. PubMed ID: 38403501
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation variations and epigenetic aging in telomere biology disorders.
Carlund O; Norberg A; Osterman P; Landfors M; Degerman S; Hultdin M
Sci Rep; 2023 May; 13(1):7955. PubMed ID: 37193737
[TBL] [Abstract][Full Text] [Related]
19. What's new in the pathogenesis and treatment of therapy-related myeloid neoplasms.
Voso MT; Falconi G; Fabiani E
Blood; 2021 Sep; 138(9):749-757. PubMed ID: 33876223
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary, Hepatic, and Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Telomere Biology Disorders.
Pennington KM; Simonetto D; Taner T; Mangaonkar AA
Curr Hematol Malig Rep; 2024 Feb; ():. PubMed ID: 38315384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
